Rifle

Serum creatinine criteria

UO criteria

AKIN criteria

Serum creatinine criteria

UO criteria

Jamal case at base line HK SHAKIL

Jamal case at conclusion of therapy HK SHAKIL

Risk

Increase in serum creatinine ≥ 1.5 × baseline or decrease in GFR ≥ 25%

< 0.5 mL∙kg⁻¹∙h⁻¹ for ≥ 6 h

Stage 1

Increasde in serum creatinine ≥ 0.3 mg dL⁻¹ (≥ 26.4 mg∙dL⁻¹) or increase ≥ 1.5 × base line

< 0.5 mL∙kg⁻¹∙h⁻¹ for ≥ 6 h

Injury

Injury increase in serum creatinine ≥ 2.0 × baseline or decrease in GFR ≥ 50%

< 0.5 mL∙kg⁻¹∙h⁻¹ for ≥ 12 h

Stage 2

Increase in serum creatinine ≥ 2 × baseline

< 0.5 mL∙kg⁻¹∙h⁻¹

for ≥12 h

Failure

Failure increase in serum creatinine ≥ 3.0 × baseline or decrease in GFR ≥ 75%

< 0.3 mL∙kg⁻¹∙h⁻¹ ≥ 24 h or anuria ≥ 12 h ≥ 12 h

Stage 3

Increase in serum creatinine ≥ 3 × baseline or serum creatinine ≥ 4.0 mg∙dL⁻¹ (354 µmol∙L⁻¹) with an acute rise of at least 0.5 mg∙dL⁻¹ (44 µmol∙L⁻¹) or initiation of RRT

< 0.3 mL∙kg⁻¹∙h⁻¹

≥ 24 h or anuria

≥ 12 h

On March 29, 2013 7.90 mg∙dL⁻¹

On April 15, 2013 0.81 mg∙dL⁻¹

Loss

Complete loss of kidney function 94 wk

ESKD

Complete loss of kidney function 93 mo